AHIP’s Opposition of “Medicare for All Act of 2019”
On April 30, 2019, AHIP submitted a statement for a hearing in the House Rules Committee that focused on the “Medicare for All Act of 2019.”
On April 30, 2019, AHIP submitted a statement for a hearing in the House Rules Committee that focused on the “Medicare for All Act of 2019.”
As part of its effort to shift more of its business towards value-based care arrangements, Louisville-based insurer Humana has launched a national Oncology Model of Care program meant to drive better treatment of cancer patients across the country.
Value-based care programs are flourishing across the U.S., with a seven-fold increase in the number of states implementing such initiatives in the past five years. That’s according to Value-Based Care in America: State-by-State, the second national study of state healthcare payment programs published by Change Healthcare.
AHIP explains their support of the Medicare Advantage Quality Payment Relief Act
CMS issued a final rule April 1 to update 2020 payment policies for Medicare Advantage and Part D prescription drug plans.
Opioid use among Blue Shield of California members with noncancer pain fell 56 percent since 2014, the health insurer said March 18.
In an effort to reduce prescription drug costs in the last year, nearly one in every five patients asked their physician for a lower-cost medication, according to a new report from the CDC.
Shifting from a fee-for-service health system to a value-based one is the most effective way to lower overall healthcare costs, a medical trade group wrote recently to a Senate panel.
Almost half — 46 percent — of adults aren't familiar with "Medicare for All" proposals, according to a survey from NORC at the University of Chicago.
Sixty-four percent of consumers reported that they would jump on an opportunity to prepay for medications to receive a discounted price, according to a survey from DrFirst, a provider of e-prescribing and patient medication management solutions.